# Paraneoplastic Pulmonary Embolism Revealing Metastatic Uterine Carcinosarcoma

**Authors:** Elias Tayar, Amira Bitar, Maroun Ibrahim

PMC · DOI: 10.1155/crom/5340586 · Case Reports in Oncological Medicine · 2026-02-27

## TL;DR

An elderly woman's unexplained pulmonary embolism led to the discovery of aggressive uterine cancer, highlighting the importance of considering hidden cancers in similar cases.

## Contribution

This case report emphasizes unprovoked pulmonary embolism as a potential early sign of metastatic uterine carcinosarcoma.

## Key findings

- Unprovoked pulmonary embolism revealed metastatic uterine carcinosarcoma in an elderly woman.
- Prompt diagnosis and treatment improved the patient's condition despite poor prognosis.
- Clinicians should suspect hidden malignancies in cases of idiopathic venous thromboembolism.

## Abstract

Venous thromboembolism (VTE) can be a paraneoplastic phenomenon and may occasionally be the first manifestation of an occult malignancy. We present the case of an elderly woman whose “unprovoked” pulmonary embolism (PE) led to the diagnosis of metastatic uterine carcinosarcoma, an aggressive endometrial cancer subtype.

A 74‐year‐old postmenopausal woman with a history of uterine fibroids and prior breast ductal carcinoma in situ developed progressive dyspnea. She was found to have bilateral PEs with right heart strain and extensive bilateral deep vein thromboses (DVTs). Imaging also revealed ascites, widespread lymphadenopathy, and an 8‐cm uterine mass. Tumor marker evaluation showed a markedly elevated CA‐125 level. Diagnostic procedures including endometrial biopsy, ascitic fluid cytology, and lymph node biopsy confirmed Stage IVB uterine carcinosarcoma. She was managed with anticoagulation for VTE and initiated on systemic chemotherapy (carboplatin plus paclitaxel), given that surgical cure was not feasible due to metastases.

After treatment initiation, the patient′s respiratory status improved, and she was discharged on long‐term anticoagulation and chemotherapy, with plans for outpatient oncology follow‐up.

This case highlights that an unexplained (unprovoked) PE in an older adult can be the harbinger of an underlying malignancy. In women, especially those with additional red flags such as abdominal distension or abnormal uterine bleeding, prompt evaluation for gynecologic cancers is warranted. Early identification of the occult cancer allowed appropriate therapy; however, uterine carcinosarcoma carries a poor prognosis once metastatic. Clinicians should maintain a high index of suspicion for hidden malignancy in cases of idiopathic VTE, as timely diagnosis can guide life‐saving interventions.

## Linked entities

- **Chemicals:** carboplatin (PubChem CID 426756), paclitaxel (PubChem CID 36314)
- **Diseases:** pulmonary embolism (MONDO:0005279), venous thromboembolism (MONDO:0005399), uterine carcinosarcoma (MONDO:0006485), endometrial cancer (MONDO:0002447), breast ductal carcinoma in situ (MONDO:0005023)

## Full-text entities

- **Genes:** MUC16 (mucin 16, cell surface associated) [NCBI Gene 94025] {aka CA125}, ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}, SPATA2 (spermatogenesis associated 2) [NCBI Gene 9825] {aka PD1, PPP1R145, tamo}
- **Diseases:** uterine fibroids (MESH:D007889), thrombocytosis (MESH:D013922), abdominal distension (MESH:D000007), sinus tachycardia (MESH:D013616), Thromboembolism (MESH:D013923), gastrointestinal malignancy (MESH:D005770), Mullerian tumor (MESH:D018200), uterine or ovarian cancers (MESH:D010051), breast ductal carcinoma in situ (MESH:D018270), anemia (MESH:D000740), ascites (MESH:D001201), PEs (MESH:D005413), mucinous gastrointestinal tumors (MESH:D046152), metastases (MESH:D009362), clot (MESH:D013927), hypertension (MESH:D006973), endometrial cancer (MESH:D016889), deficient (MESH:D007153), VTE (MESH:D054556), Stage IV disease (MESH:D007676), cough (MESH:D003371), DVT (MESH:D020246), leukocytosis (MESH:D007964), chest pressure (MESH:D013898), right ventricular dilatation (MESH:C566255), lymphadenopathy (MESH:D008206), bleeding (MESH:D006470), fatigue (MESH:D005221), hypercoagulability (MESH:D019851), strain (MESH:D013180), hemoptysis (MESH:D006469), hypotensive (MESH:D007022), pulmonary emboli (MESH:D020766), fever (MESH:D005334), PE (MESH:D011655), iron-deficiency anemia (MESH:D018798), paraneoplastic (MESH:D010257), Trousseau's syndrome (MESH:D054868), hyperlipidemia (MESH:D006949), extrauterine disease (MESH:D011271), leg pain (MESH:D010146), mastectomy (MESH:D000072656), dyspnea (MESH:D004417), diabetes (MESH:D003920), Stage IV carcinosarcoma (MESH:D002296), uterine cancers (MESH:D014594), Trousseau's syndrome of malignancy (MESH:D009369), MMR (MESH:C536928), metastatic disease (MESH:D000092182), edema (MESH:D004487)
- **Chemicals:** ifosfamide (MESH:D007069), lenvatinib (MESH:C531958), taxane (MESH:C080625), heparin (MESH:D006493), Low-molecular-weight heparin (MESH:D006495), DOACs (-), carboplatin (MESH:D016190), pembrolizumab (MESH:C582435), platinum (MESH:D010984), dostarlimab (MESH:C000719628), oxygen (MESH:D010100), paclitaxel (MESH:D017239)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12949080/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12949080/full.md

## References

9 references — full list in the complete paper: https://tomesphere.com/paper/PMC12949080/full.md

---
Source: https://tomesphere.com/paper/PMC12949080